Literature DB >> 19198915

Plasma lipid transfer enzymes in non-diabetic lean and obese men and women.

Faidon Magkos1, B S Mohammed, Bettina Mittendorfer.   

Abstract

There are considerable differences in the plasma lipid profile between lean and obese individuals and between men and women. Little, however, is known regarding the effects of obesity and sex on the plasma concentration of enzymes involved in intravascular lipid remodeling. Therefore, we measured the immunoreactive protein mass of lipoprotein lipase (LPL), hepatic lipase (HL), cholesterol-ester transfer protein (CETP) and lecithin-cholesterol acyl transferase (LCAT) in fasting plasma samples from 40 lean and 40 obese non-diabetic men and premenopausal women. Women, compared with men, had approximately 5% lower plasma LCAT (p < 0.041), approximately 35% greater LPL (p = 0.001) and approximately 10% greater CETP (p = 0.085) concentrations. Obese, compared with lean individuals of both sexes, had approximately 30% greater plasma LCAT (p < 0.001), approximately 20% greater CETP (p < 0.001) and approximately 20% greater LPL (p = 0.071) concentrations. Plasma HL concentration was not different in lean men and women. Obesity was associated with increased (by approximately 50%) plasma HL concentration in men (p = 0.018) but not in women; consequently, plasma HL concentration was lower in obese women than obese men (p = 0.009). In addition, there were direct correlations between plasma lipid transfer enzyme concentrations and lipoprotein particle concentrations and sizes. There are considerable differences in basal plasma lipid transfer enzyme concentrations between lean and obese subjects and between men and women, which may be partly responsible for respective differences in the plasma lipid profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198915      PMCID: PMC2676209          DOI: 10.1007/s11745-009-3285-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.

Authors:  T Hitsumoto; H Ohsawa; T Uchi; H Noike; M Kanai; M Yoshinuma; Y Miyashita; H Watanabe; K Shirai
Journal:  Atherosclerosis       Date:  2000-12       Impact factor: 5.162

3.  Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells.

Authors:  K L Olin; S Potter-Perigo; P H Barrett; T N Wight; A Chait
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

Review 4.  Metabolic origins and clinical significance of LDL heterogeneity.

Authors:  Kaspar K Berneis; Ronald M Krauss
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

5.  Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.

Authors:  S Matthijs Boekholdt; Jan-Albert Kuivenhoven; Nicholas J Wareham; Ron J G Peters; J Wouter Jukema; Robert Luben; Sheila A Bingham; Nicholas E Day; John J P Kastelein; Kay-Tee Khaw
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

Review 6.  Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins.

Authors:  A Zambon; S Bertocco; N Vitturi; V Polentarutti; D Vianello; G Crepaldi
Journal:  Biochem Soc Trans       Date:  2003-10       Impact factor: 5.407

7.  Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.

Authors:  Osamu Hanyu; Takashi Miida; Konen Obayashi; Tomoo Ikarashi; Satoshi Soda; Susumu Kaneko; Satoshi Hirayama; Katsunori Suzuki; Yuichi Nakamura; Keiichi Yamatani; Yoshifusa Aizawa
Journal:  Atherosclerosis       Date:  2004-06       Impact factor: 5.162

Review 8.  Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.

Authors:  S E Borggreve; R De Vries; R P F Dullaart
Journal:  Eur J Clin Invest       Date:  2003-12       Impact factor: 4.686

Review 9.  Hepatic lipase, lipoprotein metabolism, and atherogenesis.

Authors:  Silvia Santamarina-Fojo; Herminia González-Navarro; Lita Freeman; Elke Wagner; Zengxuan Nong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-29       Impact factor: 8.311

10.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

View more
  12 in total

1.  Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.

Authors:  M A Emokpae; O H Uwumarongie; H B Osadolor
Journal:  Indian J Clin Biochem       Date:  2010-12-29

2.  Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.

Authors:  Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

3.  Lipid metabolism in long-lived families: the Leiden Longevity Study.

Authors:  Anika A M Vaarhorst; Marian Beekman; Eka H D Suchiman; Diana van Heemst; Jeanine J Houwing-Duistermaat; Rudi G J Westendorp; P Eline Slagboom; Bastiaan T Heijmans
Journal:  Age (Dordr)       Date:  2010-09-03

Review 4.  Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.

Authors:  Gijs H Goossens; Johan W E Jocken; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2020-11-10       Impact factor: 43.330

Review 5.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

6.  CETP Expression Protects Female Mice from Obesity-Induced Decline in Exercise Capacity.

Authors:  David A Cappel; Louise Lantier; Brian T Palmisano; David H Wasserman; John M Stafford
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

Review 7.  Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity.

Authors:  Anne-Marie Lundsgaard; Bente Kiens
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-13       Impact factor: 5.555

8.  Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study.

Authors:  Christian Høst; Lars C Gormsen; Britt Christensen; Niels Jessen; David M Hougaard; Jens S Christiansen; Steen B Pedersen; Michael D Jensen; Søren Nielsen; Claus H Gravholt
Journal:  Diabetes       Date:  2012-11-27       Impact factor: 9.461

9.  Lecithin: cholesterol acyltransferase and na(+)-k(+)-ATPase activity in patients with breast cancer.

Authors:  Hilal Kiziltunç Ozmen; Seda Askın
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

10.  Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women.

Authors:  Ki-Hoon Park; Dhananjay Yadav; Suk-Jeong Kim; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.